Stocks
Sino Biopharmaceutical Limited (SBMFF) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| EBITDA margin, % | ? | 74.0% | 25.7% | 26.6% | 21.2% | 25.1% | 20.9% | ||
| Changes by years, y/y, % | +50pp | -48pp | +1pp | -5pp | +4pp | +35% | |||
Sino Biopharmaceutical Limited. EBITDA margin, %
Sino Biopharmaceutical Limited. EBITDA margin, changes, pp
Sino Biopharmaceutical Limited (SBMFF) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | 22.4% | 23.3% | 23.3% | 36.5% | 36.5% | 20.9% | |
| Changes by years, y/y, % | -2pp | +6pp | +7pp | +14pp | +14pp | |||
| Changes by quarters, q/q, % | 0pp | +1pp | 0pp | +13pp | 0pp | |||
